Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 29, 2015
A review of the clinical performance of the Aptima HPV assayJuliane Haedicke, Thomas Iftner
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
Human papillomaviruses and cancerJuliane Haedicke, Thomas Iftner
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infectionJuliane Haedicke, Craig Brown, Mojgan H Naghavi
International Journal of Cancer|November 14, 2018
Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapyOlga Rataj, Juliane Haedicke-Jarboui, Frank Stubenrauch, et al.
Virus Research|December 15, 2016
Involvement of Brd4 in different steps of the papillomavirus life cycleThomas Iftner, Juliane Haedicke-Jarboui, Shwu-Yuan Wu, et al.
American Journal of Cancer Research|June 25, 2014
A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivoNatalie Leiprecht, Ekaterina Notz, Johanna Schuetz, et al.
Journal of Virology|February 29, 2008
The Ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infectionJuliane Haedicke, Kenia de Los Santos, Stephen P Goff, et al.
BMC Infectious Diseases|December 10, 2014
A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-offGerd Boehmer, Lisa Wang, Angelika Iftner, et al.
Cancer Medicine|December 20, 2019
Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samplesJasmin Fertey, Jörg Hagmann, Hans-Joachim Ruscheweyh, et al.
BMC Infectious Diseases|November 13, 2016
Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimensThomas Iftner, Lisa Wang, Angelika Iftner, et al.
Pageof 2